Search hospitals > South Carolina > Columbia
Prisma Health Richland Hospital
Claim this profileColumbia, South Carolina 29203
Global Leader in Cancer
Global Leader in Adult T-Cell Leukemia/Lymphoma
Conducts research for Relapse
Conducts research for Acute Lymphoblastic Leukemia
Conducts research for Brain Tumor
196 reported clinical trials
13 medical researchers
Summary
Prisma Health Richland Hospital is a medical facility located in Columbia, South Carolina. This center is recognized for care of Cancer, Adult T-Cell Leukemia/Lymphoma, Relapse, Acute Lymphoblastic Leukemia, Brain Tumor and other specialties. Prisma Health Richland Hospital is involved with conducting 196 clinical trials across 478 conditions. There are 13 research doctors associated with this hospital, such as Ki Chung, MD, Stuart L. Cramer, Jeffrey K. Giguere, and Patrick McCann, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Adult T-Cell Leukemia/Lymphoma
Global LeaderStage II
CD19 positive
FLT3 negative
Top PIs
Ki Chung, MDPrisma Health Cancer Institute - Eastside6 years of reported clinical research
Expert in Cancer
Expert in Parotid Gland Cancer
97 reported clinical trials
199 drugs studied
Stuart L. CramerPrisma Health Richland Hospital5 years of reported clinical research
Expert in Cancer
Expert in Brain Tumor
56 reported clinical trials
107 drugs studied
Jeffrey K. GiguerePrisma Health Cancer Institute - Faris8 years of reported clinical research
Studies Cancer
Studies Breast Cancer
26 reported clinical trials
64 drugs studied
Patrick McCann, MDPrisma Health4 years of reported clinical research
Studies Congestive Heart Failure
Studies Heart Failure
4 reported clinical trials
5 drugs studied
Clinical Trials running at Prisma Health Richland Hospital
Cancer
Testicular cancer
Wilms Tumor
Adult T-Cell Leukemia/Lymphoma
Acute Lymphoblastic Leukemia
Stroke
Heart Failure
Testicular Carcinoma
Acute Myeloid Leukemia
Germ Cell Tumors
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Various Treatments
for Wilms Tumor
This phase III trial studies using risk factors in determining treatment for children with favorable tissue (histology) Wilms tumors (FHWT). Wilms Tumor is the most common type of kidney cancer in children, and FHWT is the most common subtype. Previous large clinical trials have established treatment plans that are likely to cure most children with FHWT, however some children still have their cancer come back (called relapse) and not all survive. Previous research has identified features of FHWT that are associated with higher or lower risks of relapse. The term "risk" refers to the chance of the cancer coming back after treatment. Using results of tumor histology tests, biology tests, and response to therapy may be able to improve treatment for children with FHWT.
Recruiting2 awards Phase 34 criteria
Thoracotomy vs Thoracoscopy
for Metastatic Osteosarcoma
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Recruiting2 awards Phase 37 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Prisma Health Richland Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.